Download PDF
Thromb Haemost 2002; 87(05): 918
DOI: 10.1055/s-0037-1613107
Letters to the Editor
Schattauer GmbH

Is a Nihilistic Attitude to Thrombophilia Screening Justified?

Beverley J. Hunt
1   Dept. of Haematology, Guy’s & St. Thomas, Trust, London
,
Muriel Shannon
2   Dept. of Haematology, St. George’s Hospital London, UK
,
David Bevan
2   Dept. of Haematology, St. George’s Hospital London, UK
,
Vicky Murday
2   Dept. of Haematology, St. George’s Hospital London, UK
› Author Affiliations
Further Information

Publication History

Received 23 January 2002

Accepted after resubmission 14 February 2002

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C. Prediction of a cofactor for activated Protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
    CrossrefPubMedGoogle Scholar
  • 2 Bertina RM, Koelman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. et al. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994; 369: 64-7.
    CrossrefPubMedGoogle Scholar
  • 3 Greaves M, Baglin T. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease. Brit J Haematol 2000; 109: 699-703.
    CrossrefPubMedGoogle Scholar
  • 4 Mannucci PM. Genetic hypercoagulability: prevention suggests testing family members. Blood 2001; 98: 21-2.
    CrossrefPubMedGoogle Scholar